Heart failure & cardiomyopathies

Baroreflex Activation Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Single-Centre Experience

ESC Heart FailPublished Retrospective registry study

Authors' conclusion

Patients with HFrEF who are selected for BAT are in a stage of worsening or even advanced heart failure. BAT appears to be safe and improves clinical symptoms and-to a modest degree-left ventricular function. The risk of death remains high in advanced disease stages.

Study context

Population
Heart failure with reduced ejection fraction (HFrEF), New York Heart Association (NYHA) III–IV, left ventricular ejection fraction (LVEF) <35% despite guideline-directed medical therapy, 2014–2020
Participants
30 participants
Outcome
NYHA class, LVEF and NT-proBNP from baseline to 12 months
Follow-up
12 months
Methodological detailsnon-randomized, single-centre, Device implantation successful in all patients
  • Non-randomized
  • Single-centre
  • Device implantation successful in all patients

Main finding

As reported in the abstract

NYHA class improved in 19 patients, unchanged in 5 (baseline III/IV: 26 (87%)/4 (13%))
P < 0.001
LVEF, median (IQR): 25.5 (20.0-30.5) % at baseline vs 30.0 (25.0-36.0) % at 12 months
P = 0.014
N-terminal prohormone of brain natriuretic peptide (NT-proBNP), median (IQR): 3165 (880-8085) vs 1001 (599-3820) pg/mL, numerical decrease not significant
P = 0.526

Observational data: associations, not effects.

Further findings

Mortality · 1 and 3 years

Mortality at 1 year
n = 6, 20%
Mortality at 3 years
n = 10, 33%
As expected by MAGGIC risk score
NYHA class and estimated glomerular filtration rate (eGFR) independent predictors of mortality
  • Median follow-up 16 (10-33) months

Clinical events by baseline status

Event rate high with NYHA IV, NT-proBNP >1600 pg/mL or eGFR <30 mL/min at baseline

Original publication

Baroreflex Activation Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Single-Centre Experience. ESC Heart Fail. Published 4 September 2023. doi:10.1002/ehf2.14508

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.